Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure.

Glucocorticoids (GCs) are important regulators of metabolic control in mammals and their aberrant function has been associated with several pathologies. GCs are widely used in human and veterinary clinical practice as a potent anti-inflammatory and G.Pig Serum Albumin immune suppressive agent. Dyslipidemia is a consequence that is often observed GC treatment, is characterized by increased lipolysis, lipid mobilization, liponeogenesis, and adipogenesis.

Dogs with excess GC events hyperlipidemia, hypertension, and higher risk of developing diabetes mellitus type 2, but lower the risk of developing atherosclerotic lesions compared to humans. This study aims to examine changes in the dog lipidome plasma in experimentally induced models of short-term and long-term GC excess. Both treatments led to significant changes in plasma lipidome, clearer after long-term exposure to steroid excess.

In particular, monohexosylceramides, phosphatidylinositols, phosphatidylcholines ether, acyl phosphatidylcholines, triglycerides and sphingosine 1-phosphate showed a significant change. Now the study highlights the hitherto unknown effect of GCS on lipid metabolism, which will be important in further explanation of the role and function of GCS as a drug and the metabolic and cardiovascular diseases.

Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure.

In vitro assessment of the long-term stability of the inhibitory effect of plasma of dogs and cats on MMP 2 and 9.

To evaluate the effect of increasing the storage time on the inhibitory effect of plasma of dogs and cats in the matrix metalloproteinase (MMP) 2 and 9 in vitro.Matrix metalloproteinase 2 and 9 activity in the presence of a dog plasma stored for 57, 155, 222, 316, 367, and 438 days and plasma cats kept for 17, 198, 565, and 954 days was tested using a commercially available colorimetric assay kit.

For dog plasma, the activity of MMP 2 for the Goat Plasma older samples did not differ significantly from the 57- day samples (P = 0, 2025-.9033). Two samples of dogs has significantly lowered the activity of MMP-9 from the sample 57 days (367 days: P = 0.0099, 438 day: P = 0.0348, P = 0.0778 to 0.9928 else).

For plasma cats, storage time did not significantly affect inhibition of MMP 2 and MMP 9 activity (ANOVA, P = 0.2688 and P = 0.2404, respectively) .Increasing storage time did not significantly decrease the activity of plasma MMP inhibiting 2 and 9 for up to 14 months in dogs and 31 months in cats.

Comments

Platelet-rich plasma affects the proliferation of canine bone marrow-derived mesenchymal stromal cells in vitro.

reported the efficacy of platelet rich plasma (PRP) in regenerative medicine contradictory. We validated the PRP effect on cell proliferation dog bone marrow-derived multipotent mesenchymal stromal (K9BMMSCs) in vitro. PRP is extracted from the Feline Serum blood of six dogs with osteoarthritis. K9BMMSCs established from the bone marrow and is characterized for CD90 and CD19 expression by immunocytochemistry. PRP concentration influence on the survival of autologous K9BMMSCs suitable validated using MTS assay. Positive negative CD90 and CD19 expression was confirmed MSC origin. PRP at concentrations volume / volume increased 40%, while PRP at 80 and 100% v / v concentration tested suppressed viability K9BMMSCs.PRP concentration play an important role in the survival of K9BMMSCs, which can affect tissue repair in vivo. The ability to distinguish four plasma biomarkers in canine hip dysplasia. The accumulation of breakdown products of cartilage in the body fluids have been studied...

Assessment of the Efficacy of Platelet-Rich Plasma in the Treatment of Traumatic Canine Fractures.

Role of platelet rich plasma (PRP) to promote fracture healing has not been stated clearly. The aim of this prospective clinical study was to evaluate the effectiveness of plasma rich in growth factors (PRGF, derivate PRP) in the treatment of bone fracture occurs naturally in dogs. With the goal, sixty-five-dog with Goat Serum a radius / ulna or tibia / fracture of the fibula were randomly divided into two groups (PRGF and saline solution (SS) group) and examined at days 0, 7, 14, 21, 28, 35, 42, 49, 56, 60, 63, 70, 120, and 180. All fractures treated with external skeletal fixation, and pain is controlled with carprofen. Healing was evaluated by physical examination, limb function, radiographic, and by Likert-type questionnaires owner satisfaction. A more rapid healing of fractures observed in PRGF group, with a statistically significant difference against the SS. Swelling at the site of fracture was significantly greater at 14 and 28 days in animals injected with t...

Determination of Reduced and Oxidized Coenzyme Q10 in Canine Plasma and Heart Tissue by HPLC-ECD: Comparison with LC-MS/MS Quantification.

Coenzyme Q10 (Q10) plays an important role in mammals for energy production in the mitochondria, and as a powerful antioxidant. Oxidation Ratio (% oxidized in relation to the amount of Q10) has been proposed as an important biomarker. An HPLC-ECD method is sensitive and Equine Serum Albumin reproducible developed for the determination of reduced and oxidized Q10 in dog plasma and heart tissue. chromatographic separation is achieved within 10 minutes by using the column Waters Nova-pak C18 and the mobile phase with lithium perchlorate in ethanol / methanol / 2-propanol. validation show satisfactory results. a very good linear correlation was found (r 2> 0.9997), intra- and inter-day precision were below 6.5% (n = 5) and the recovery is between 89 and 109% (n = 5). The sensitivity is expressed as the Lower Limit Quantification (LLOQ) was 10 nM. acceptable stability of both samples extracted and un-extracted observed. Total plasma concentration range Q10 is found betw...

Canine Plasma

Search This Blog